Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.
Designer Baby Companies Are in Turmoil
Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.
Science & Tech
Editorial note: This article represents original analysis and commentary by the TechDailyPulse editorial team.